Adient opened higher at $16.04, compared with its previous close of $16.01. In the last trading session, the stock traded between $15.58 and $16.18. It showed a downward intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in Adient is now worth
$ 35.62
Resulting in a loss of
$ 64.38 (64.38%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 7 Analysts
Buy
57.14%
Hold
28.57%
Sell
14.29%
Markets Today
Today's Change
$-0.19 (-1.17%)
Day High
$16.18
Day Low
$15.58
Day Open
$16.04
Prev Close
$16.01
Volume
6,64,365
1W Return
-7.96%
1M Return
-8.52%
3M Return
-17.28%
6M Return
-28.47%
1Y Return
-23.01%
Fundamentals
Market Cap ($ Mn)
1,220
PE Ratio
34.65
PB Ratio
0.85
PEG Ratio
0.45
ROE
-10.36%
ROCE
1.68%
EPS (TTM)
$0.32
Investment Returns
1 Week
-7.96%
1 Month
-8.52%
3 Months
-17.28%
6 Months
-28.47%
9 Months
-40.67%
Financials
Quarterly
All values in $ Mn
3.6K
Mar 25
3.7K
Jun 25
3.7K
Sep 25
3.6K
Dec 25
3.9K
Mar 26
3.9K
Jun 26
Updates
6Nov
JP Morgan maintains Overweight on Adient, cuts price target to $23
JP Morgan maintains Overweight rating on Adient plc. Price target lowered from $25 to $23 by analyst Rajat Gupta. Valuation revision reflects updated market or earnings assumptions.
7 days ago
4Nov
Adient adds $400M to buyback, raising total authorization to $1B
Adient PLC increased its share repurchase authorization by $400 million. Total buyback authorization now stands at $1 billion with $435 million remaining. Company adopted a Tax Benefits Preservation Plan to protect net operating loss carryforwards. Existing program since November 2022 has seen $565 million in share repurchases.
Adjusted EPS of $0.52 missed the $0.58 consensus estimate by 10.34%. Quarterly sales of $3.730 billion beat the $3.604 billion estimate by 3.49%. Revenue increased 1.14% year-over-year from $3.688 billion. Adjusted EPS remained unchanged from the same period last year.
8 days ago
19Oct
Stifel maintains Buy on Adient, lowers price target to $21
Stifel analyst Nathan Janes maintained a Buy rating on Adient plc. Price target lowered from $26 to $21. Rating remains unchanged despite the reduction in valuation.
24 days ago
9Oct
Barclays maintains Equal-Weight on Adient, lowers price target to $22
Barclays lowered Adient's price target from $25 to $22. Analyst Dan Levy maintained an Equal-Weight rating. The revision reflects a adjusted valuation perspective.
1mo ago
18Sep
Adient appoints Peter Carlin as CFO, succeeding Mark Oswald
Peter Carlin appointed as Adient's new CFO. Role effective November 16, 2026. Succeeds outgoing CFO Mark Oswald. Carlin joins as VP finance on Oct. 1, 2026. Stepping down from Adient's board of directors.
